🔎 Trials Near Me

Home › NCT06212947

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

RecruitingObservational study

Who can join

Up to age 15 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Participants must be ≤ 15 years old at the time of signing the informed consent
* Participants must have genetic confirmation of Hypochondroplasia diagnosis

Exclusion Criteria:

* Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
* Received an investigational product or medical device within 6 months before the Screening visit

About the study

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.

Sponsor: BioMarin Pharmaceutical · Participants: 400 · Started: Nov 27, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06212947

Locations in the U.S.

ArizonaPhoenix Children's Hospital, Phoenix
CaliforniaCedars-Sinai Medical Center, Los Angeles (Not yet recruiting)
UCSF Benioff Children's Hospital, Oakland
DelawareNemours Alfred I. Dupont Hospital for Children, Wilmington
District of ColumbiaChildren's National Health System, Washington D.C.
IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago, Chicago
MarylandThe Johns Hopkins University School of Medicine, Baltimore (Not yet recruiting)
MassachusettsBoston Children's Hospital, Boston
MinnesotaUniversity of Minnesota Masonic Children's Hospital, Minneapolis
MissouriUniversity of Missouri, Columbia
Washington University School of Medicine in St. Louis, St Louis
New YorkMount Sinai Kravis Children's Hospital, New York
OhioAkron Children's Hospital, Akron (Not yet recruiting)
Nationwide Children's Hospital, Columbus (Not yet recruiting)
TexasCook Children's Endocrinology, Fort Worth
WisconsinMedical College of Wisconsin, Children's Hospital, Milwaukee

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.